NDC 0169-2662

Tresiba

Insulin Degludec Injection

Tresiba is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Degludec.

Product ID0169-2662_b7aeb64e-5f1b-458e-ae42-e89ba622a60a
NDC0169-2662
Product TypeHuman Prescription Drug
Proprietary NameTresiba
Generic NameInsulin Degludec Injection
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2018-11-21
Marketing CategoryBLA / NDA
Application NumberBLA203314
Labeler NameNovo Nordisk
Substance NameINSULIN DEGLUDEC
Active Ingredient Strength100 U/mL
Pharm ClassesInsulin [CS],Insulin Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0169-2662-11

1 VIAL, GLASS in 1 CARTON (0169-2662-11) > 10 mL in 1 VIAL, GLASS
Marketing Start Date2019-02-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0169-2662-90 [00169266290]

Tresiba INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA203314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-05

NDC 0169-2662-11 [00169266211]

Tresiba INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA203314
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-02-05

Drug Details

Active Ingredients

IngredientStrength
INSULIN DEGLUDEC100 U/mL

OpenFDA Data

SPL SET ID:456c5e87-3dfd-46fa-8ac0-c6128d4c97c6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1670023
  • 1670011
  • 2107520
  • 1670021
  • 1670016
  • 2107522
  • Pharmacological Class

    • Insulin [CS]
    • Insulin Analog [EPC]

    NDC Crossover Matching brand name "Tresiba" or generic name "Insulin Degludec Injection"

    NDCBrand NameGeneric Name
    0169-2550Tresibainsulin degludec injection
    0169-2660Tresibainsulin degludec injection
    0169-2662Tresibainsulin degludec injection
    50090-3491Tresibainsulin degludec

    Trademark Results [Tresiba]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TRESIBA
    TRESIBA
    79080004 3841743 Live/Registered
    Novo Nordisk A/S
    2010-02-03

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.